Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approach
Minor changes in the quality of biologically manufactured monoclonal antibodies (mAbs) can affect their bioactivity and efficacy. One of the most important variations concerns the N-glycosylation pattern, which directly affects an anti-tumor mechanism called antibody-dependent cell-meditated cytotox...
Saved in:
Main Authors: | Joanna Hajduk (Author), Cyrill Brunner (Author), Sebastian Malik (Author), Jana Bangerter (Author), Gisbert Schneider (Author), Marco Thomann (Author), Dietmar Reusch (Author), Renato Zenobi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody
by: David Falck, et al.
Published: (2021) -
Latest Advances in Glycoengineering
Published: (2020) -
A versatile design platform for glycoengineering therapeutic antibodies
by: Seth D. Ludwig, et al.
Published: (2022) -
Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy
by: Yi Li, et al.
Published: (2023) -
Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model
by: David Falck, et al.
Published: (2022)